Fabio M Iwamoto

9PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Radiation therapyGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 01, 2026
Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial.

|Mar 17, 2026
Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Leon D Kaulen, Lakshmi Nayak, Philipp Karschnia

|Nov 08, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma.

Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak

|Aug 23, 2023
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas.

Connor J Kinslow, Ali I Rae, Kekoa Taparra

|Apr 16, 2023
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.

Prabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn

|Feb 05, 2022
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.

Víctor A Arrieta, Andrew X Chen, J Robert Kane

Pageof 2

Frequent Collaborators

4 joint publications

Adam M Sonabend

4 joint publications

Raul Rabadan

4 joint publications

Jeffrey N Bruce

3 joint publications

Ali I Rae